Pevion's therapeutic Candida vaccine generates functional B cell memory in all vaccinees
Ittigen, Switzerland (ots) - Pevion Biotech AG today announced further data from the ongoing clinical study of its therapeutic Candida vaccine PEV7, demonstrating the generation of specific and functional B cell memory in 100% of vaccinees. Furthermore, the results again confirm the capability of Pevion's second generation virosomal vaccine platform to induce strong ...